Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Athersys Inc (NQ: ATHX )

0.4321 +0.0741 (+20.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 840,191
Open 0.4501
Bid (Size) 0.3850 (15)
Ask (Size) 0.4300 (2)
Prev. Close 0.3580
Today's Range 0.3760 - 0.4501
52wk Range 0.2560 - 2.760
Shares Outstanding 226,255,093
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Performance

YTD
-46.52%
-46.52%
1 Month
-11.40%
-11.40%
3 Month
-52.72%
-52.72%
6 Month
-58.45%
-58.45%
1 Year
-76.64%
-76.64%

More News

Read More
Grant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney Transplantation
From Athersys, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
AMAT Stock Alert: Analysts Raise Applied Materials Price Targets After Earnings
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Athersys (ATHX) Stock Down 36% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Athersys, Inc. Announces Pricing of $3.5 Million Public Offering
From Athersys, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Athersys Reports Second Quarter 2023 Financial Results and Business Highlights
From Athersys, Inc.
Via Business Wire
Athersys Appoints Neema Mayhugh, PhD to its Board of Directors
From Athersys, Inc.
Via Business Wire
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Athersys to Host Business Update Conference Call on August 9th
From Athersys, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
Via Benzinga
Why Tattooed Chef Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Patient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic Trauma
From Athersys, Inc.
Via Business Wire
Athersys Restructures Debt with Supplier
From Athersys, Inc.
Via Business Wire
Athersys Reports First Quarter 2023 Financial Results and Business Highlights
From Athersys, Inc.
Via Business Wire
Athersys to Participate in Three Upcoming Conferences
From Athersys, Inc.
Via Business Wire
Athersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Conference
From Athersys, Inc.
Via Business Wire
Athersys to Participate in The American Society for Neural Therapy and Repair Annual Conference
From Athersys, Inc.
Via Business Wire
Athersys, Inc. Announces Closing of $3.7 Million Registered Direct Offering and Concurrent Private Placement
From Athersys, Inc.
Via Business Wire
Why Athersys Shares Are Falling During Tuesday's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.